Hims & Hers Health (HIMS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Hims & Hers Health (HIMS) is Neutral.

The composite score behind that read is +0.01, weighing +0.27 of bullish evidence against -0.33 bearish.

Hims & Hers Health last closed at $30.92, +10.19% on the session.

Against the IVW growth benchmark the position is +9.39% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 60%.

16 graded predictions for HIMS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Hims & Hers Health in the 23rd percentile on return on equity, where 100 is best.

Hims & Hers Health is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $6.55B.

StockMap tracks Hims & Hers Health as the 25th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Hims & Hers Health ranks 39th of 85 in the group, against a group median of +0.00.